David J. Perry

Dose Modification for PDQ.

Daniel R. Masys, Susan Molloy Hubbard, David J. Perry, 1987 .

Is the prothrombin 3 ' UTR gene polymorphism a risk factor for the development of Budd-Chiari syndrome?

Gjm Webster, David J. Perry, James O'Beirne, 1999 .

Hemostasis and thrombosis protocols

David J. Perry, D. Perry, K. Pasi, 1999 .

A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies

Sylvia Richardson, Kathleen Stirrups, Wendy N. Erber, 2016, Science Translational Medicine.

De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures

Henning Gall, Fengyuan Hu, Kevin Rue-Albrecht, 2018, American journal of human genetics.